You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

RENORMAX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Renormax patents expire, and when can generic versions of Renormax launch?

Renormax is a drug marketed by Schering and is included in one NDA.

The generic ingredient in RENORMAX is spirapril hydrochloride. Additional details are available on the spirapril hydrochloride profile page.

Summary for RENORMAX
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 32
Patent Applications: 4,668
DailyMed Link:RENORMAX at DailyMed
Drug patent expirations by year for RENORMAX

US Patents and Regulatory Information for RENORMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for RENORMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 ⤷  Try a Trial ⤷  Try a Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for RENORMAX

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0050800 96C0028 Belgium ⤷  Try a Trial PRODUCT NAME: PORFIMERE SODIQUE; NAT. REGISTRATION NO/DATE: NL 19150 19960409; FIRST REGISTRATION: NL - RVG 16652 19940411
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.